Ongoing clinical trials

We’re dedicated to breaking boundaries through clinical studies and to finding new and improved ways to treat cancer that deliver better life outcomes for our patients

Ongoing clinical trials 21 clinical trials

Heart Disease


Syncope/Cardiac arrhythmia for investigation

To confirm the safety and efficacy of an implantable cardiac monitor (ICM) in patients who require long term cardiac monitoring due to suspected cardiac arrhythmia or unexplained syncope.

Ongoing 2020 Auchenflower QLD, Bundaberg QLD, Doncaster East VIC

Heart Disease

Cardialen AF CL007

Atrial Fibrillation

Ongoing 2020 Doncaster East VIC, Berwick VIC, Leabrook SA, Greenslopes SA

Heart Disease


Type 2 Diabetes with Cardiovascular Disease

To assess the effects and compare 2 medications on cardiovascular outcomes in patients with type 2 diabetes and established cardiovascular disease.

Ongoing 2020 Joondalup WA, Murdoch WA

Heart Disease


Heart Failure

To collect data and evaluate the safety of Cardiac Resynchronisation Therapy (CRT) by utilising new techniques and investigational systems for patients in heart failure.

Ongoing 2020 Doncaster East VIC

Heart Disease


Heart Failure

To evaluate the efficacy and safety of a new device using Cardiac Contractility Modulation (CCM) therapy in patients with heart failure.

Ongoing 2020 Murdoch WA, Bunbury WA, Leabrook SA, Bundaberg QLD

Benign Conditions


Connective Tissue Disorders

GenesisCare is recruiting patients with Dupuytren’s Disease for a research study called ‘DEPART’.

Ongoing 2020 Newcastle NSW, Concord NSW, Hurstville NSW, Frankston VIC, Kurralta Park SA, Adelaide SA

Heart Disease


Heart Failure and Cardiac Resynchronisation Therapy

A significant number of patients with heart failure implanted with a Cardiac Resynchronisation Therapy (CRT) device fail to respond to therapy. The cause of this non-response is yet to be determined. 

Ongoing 2019 Leabrook SA, Auchenflower QLD, Murdoch WA, Bundoora VIC

Heart Disease


Aortic Valve Stenosis

To evaluate a new valve, the Portico™ NG Transcatheter Aortic Heart Valve, in patients who have symptomatic, severe aortic stenosis and are determined to be at high or extreme surgical risk.

Ongoing 2019 Leabrook SA, Auchenflower QLD, Brisbane QLD

Heart Disease


Atrial fibrillation

To evaluate a new implantable device, the Watchman FLX in patients with non-valvular atrial fibrillation who have an increased stroke risk.

Ongoing 2019 Greenslopes QLD

Heart Disease

TactiFlex PAF IDE

Atrial Fibrillation

Ongoing 2020 Auchenflower QLD

Heart Disease


Cardiovascular disease and obesity

To evaluate if treatment with a new medication reduces the risk of cardiovascular disease in overweight or obese patients.

Ongoing 2019 Auchenflower QLD, Joondalup WA




This is a randomised trial to determine how safe and effective Barrigel is when used to create space between the prostate and rectum to decrease the radiation dose and side effects to the rectum

Ongoing 2020 Ringwood VIC, Frankston VIC, Footscray VIC, St Vincent's Melbourne VIC, Epping VIC



Early Breast Cancer

To assess whether adjuvant therapy alone is no worse than adjuvant therapy plus axillary treatment, in terms of axillary recurrence within 5 years.

Ongoing 2019 Newcastle NSW, Murdoch WA

Heart Disease


Heart Failure Device

To evaluate a new heart failure sensing device in patients with heart failure.

Ongoing 2019 Auchenflower QLD

Heart Disease


Heart Failure due to mitral valve regurgitation

To evaluate a new valve in patients with severe mitral regurgitation.

Ongoing 2019 Leabrook SA, Auchenflower QLD, Doncaster East VIC, Murdoch WA



Early Breast Cancer

A unique opportunity to improve personalised use of radiation therapy in patients with early breast cancer according to their individual risks of local recurrence.

Ongoing 2019 Newcastle NSW, Wesley Medical Centre QLD, Frankston VIC, Ringwood VIC



Brain cancer

This study will help ensure the optimal targeting of anti-cancer treatment and imaging in the future.

Ongoing 2019 Newcastle NSW

Heart Disease


Cardiovascular disease

To evaluate if treatment with additional cholesterol lowering medication reduces the risk of major cardiovascular events in patients at high cardiovascular risk.

Ongoing 2019 Leabrook SA, Auchenflower QLD, Bundaberg QLD, Joondalup WA, Berwick VIC, Ringwood VIC

Heart Disease



To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy.

Ongoing 2019 Heidelberg VIC, Bundoora VIC, Mulgrave VIC, Berwick VIC, Ringwood VIC, Doncaster East VIC, Murdoch WA, Auchenflower QLD

Heart Disease


Heart failure

To evaluate a new medication for the treatment of patients in heart failure with a reduced ejection fraction and with iron deficiency.

Ongoing 2019 Auchenflower QLD



Skin registry

To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions.

Ongoing 2019 Newcastle NSW, Mater Hospital NSW, Wembley WA, Joondalup WA, Wesley Medical Centre QLD, Bundaberg QLD

No Results